Mumbai, Nov. 21 -- Developed by Prof. Claudio De Simone, DSS combines eight carefully selected bacterial strains in precise proportions, chosen for their unique biochemical and enzymatic profiles, to act synergistically on gastrointestinal physiology.

The formulation is backed by over 80 clinical trials and more than 200 scientific publications over the past two decades. It is also recommended by leading American and European gastroenterology associations for managing gastrointestinal disorders. Alkem has in-licensed the formulation from Next Gen Pharma India.

The DSS range will be available in four strengths: 225 billion CFU sachet, 112.5 billion CFU capsule, 45 billion CFU capsule, and 10 billion CFU capsule. Alkem becomes the first c...